E CFA RE 01 Budesonide Bp 160 Mcg Formoterol Fumarate 4 DOT 5 Mcg Dry Powder Multi Unit Dose Inhaler
E CFA RE 01 Budesonide Bp 160 Mcg Formoterol Fumarate 4DOT5 Mcg Dry Powder Multi Unit Dose Inhaler
Tender Timeline
Tender Title:
E CFA RE 01 Budesonide Bp 160 Mcg Formoterol Fumarate 4 DOT 5 Mcg Dry Powder Multi Unit Dose Inhaler
Reference Number:
2b11b8044
Issuing Authority:
Department of Military Affairs, Ministry of Defence
Scope of Work and Objectives:
The primary objective of this tender is to procure Budesonide Bp 160 Mcg Formoterol Fumarate 4 DOT 5 Mcg Dry Powder Multi Unit Dose Inhalers. This tender encompasses the supply of a total quantity of 14,789 inhalers which are to be delivered in a timely and efficient manner, adhering to the prescribed specifications of the Department of Military Affairs. The inhalers are intended for use in medical settings where respiratory therapy is necessary, further contributing to the health and wellbeing of personnel in the armed forces.
Eligibility Criteria:
Bidders must meet specific eligibility requirements, including but not limited to:
- Being a registered pharmaceutical manufacturer or supplier.
- Possessing the necessary licenses and certifications to distribute medicinal products.
- Compliance with applicable regulatory standards set forth by health authorities.
Technical Requirements:
Bidders must ensure that the inhalers comply with the following technical specifications:
- Must be Budesonide and Formoterol based, with exact dosages of 160 Mcg and 4.5 Mcg respectively.
- The product should be in a dry powder multi-unit dose format for optimal delivery.
- Must meet all relevant quality standards and regulations for pharmaceutical products.
Financial Requirements:
Bidders are required to submit a financial proposal outlining their pricing structure for the total quantity required. The proposal must detail payment terms, along with any additional costs associated with packaging, delivery, and handling.
Document Submission Details:
All submitted documents must be in accordance with the submission guidelines provided. Bidders are advised to ensure that their proposals are complete and submitted by the stipulated deadlines in the tender announcement.
Special Provisions:
This tender may include provisions favoring Micro, Small, and Medium Enterprises (MSEs) and startups, promoting local procurement initiatives that align with current government policies.
Evaluation Process:
The evaluation of bids will be conducted based on:
- Compliance with technical specifications.
- Financial competitiveness.
- Past performance and experience.
Bids will be assessed following a structured methodology, ensuring transparency and fairness throughout the selection process.
Delivery Locations:
The delivery of inhalers will be directed to specified military facilities as outlined by the Department of Military Affairs. Bidders should ensure their logistical capabilities meet the delivery requirements.
Contact Information:
For further inquiries regarding this tender, bidders should refer to the contact details specified by the Department of Military Affairs in the official tender documentation.
Tender BOQ Items
31 ItemsGeneral Information
Financial Information
Evaluation and Technical Information
Tender Documents
6 DocumentsDocuments Required from Seller
- Experience Criteria
- Past Performance
- Bidder Turnover
- Certificate (Requested in ATC)
- OEM Authorization Certificate
- OEM Annual Turnover
- Additional Doc 1 (Requested in ATC)
- Compliance of BoQ specification and supporting document *In case any bidder is seeking exemption from Experience / Turnover Criteria
- the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer
Similar Tenders
Frequently Asked Questions
The eligibility requirements include being a registered entity, with all essential licenses to manufacture and distribute pharmaceutical products. Bidders must also comply with the Department of Military Affairs regulations and quality standards pertinent to medicinal products.
The inhalers must contain Budesonide at a dosage of 160 Mcg and Formoterol at 4.5 Mcg. They should be delivered in a dry powder multi-unit dose format and adhere to all applicable quality standards established by relevant health authorities.
Bidders must outline a financial proposal detailing their pricing strategy for the total quantity of inhalers. Payment terms will be included in the financial submission, and bidders must be transparent about any additional expenses related to packaging and delivery.
Tender documents must be submitted electronically through the designated platform or in the specified format detailed in the tender announcement. Bidders must ensure compliance with submission guidelines to avoid disqualification.
Micro, Small, and Medium Enterprises (MSEs) and startups may benefit from specific provisions aimed at promoting local industry participation. These may include relaxed financial criteria, additional evaluation points, or other supportive measures intended to encourage bids from smaller entities.
Probable Bidders
Get Tender Alerts
Get notifications for similar tenders